<<

The Preqin Quarterly: , Q3 2012

This report is an excerpt from: Preqin Quarterly: Private Equity, Q3 2012. To download the full report please visit: https://www.preqin.com/docs/quarterly/PE/Private_Equity_Quarterly_Q3_2012.pdf

Largest Deals and Exits; Deals by Value and Stage

Fig. 42: Average Value of Venture Capital Deals by Stage, Fig. 43: Proportion of Number and Aggregate Value of Venture 2010 - 2012 YTD Capital Deals by Industry, Q3 2012

45 30% 28% 40 25% 35 21% 22% 30 20% 18% 25 17% 16% 15% 20 12% 15 10% 8% 8% 7% 6% 10 5%

Average Deal Size ($mn) Average 5% 4% 4% 5% 4% 3% 5 2% 3% 3% 2% 2% 0 0% Other Seed Debt Angel/ Angel/ Disc. Venture Other IT Internet Business Series B/ Series Round 2 Services Round 1 Round 3 Series A/ Series Series C/ Series Growth Round 4 Round Series D/ Series Capital/ Related Telecoms and Later Industrials Semic. & & Semic. Expansion Consumer Electronics Cleantech Software & Healthcare Unspecified 2009 2010 2011 2012 YTD No. of Deals Aggregate Value of Deals Source: Preqin Venture Deals Analyst Source: Preqin Venture Deals Analyst Fig. 44: 10 Largest Venture Capital Deals, Q3 2012

Deal Size Name Date Stage Investors Primary Industry Location (mn) Square Sep-12 Series D/Round 4 200 USD Citi Ventures, Rizvi Traverse Management, Starbucks Mobile Payments US Aug-12 Series D/Round 4 150 USD Accel Partners, Iconiq Capital, Naspers, Tiger Global Management Internet India Bessemer Venture Partners, Draper Fisher Jurvetson, General / Box.net, Inc. Jul-12 125 USD Atlantic, New Enterprise Associates, SAP Ventures, Scale Venture Cloud Computing US Expansion Partners, The Social+Capital Partnership Andreessen Horowitz, Atomico, Baroda Ventures, DOCOMO Fab.com Jul-12 Series C/Round 3 105 USD Capital, First Round Capital, Mayfi eld Fund, Menlo Ventures, Internet US Pinnacle Ventures, ru-Net Ltd. Elevance Renewable Jul-12 Series E/Round 5 104 USD Genting Genomics Limited, Total Energy Ventures Chemicals US Sciences, Inc. CureVac Sep-12 Series D/Round 4 80 EUR dievini Hopp BioTech holding GmbH & Co. KG Pharmaceuticals Germany Fisker Automotive, Unspecifi ed Sep-12 104 USD - Clean Technology US Inc. Round GitHub Inc. Jul-12 Series A/Round 1 100 USD Andreessen Horowitz Software US Unspecifi ed Agentschap NL, DEMCON, Hoving & Partners, Parcom Capital, Mapper Lithography Aug-12 80 EUR Semiconductors Netherlands Round RUSNANO, Technolution Unspecifi ed Desire2Learn Sep-12 80 USD New Enterprise Associates, OMERS Ventures Software Canada Round Source: Preqin Venture Deals Analyst

Fig. 45: Five Notable Venture Capital Exits, Q3 2012

Total Known Exit Name Date of First Investors (Entry) Funding Exit Exit Acquirer (Exit) Value Primary Industry Location Investment (mn) Type Date ($mn) Andreessen Horowitz, Lightspeed Venture Trade Nicira Networks Jun-09 Partners, New Enterprise Associates 40 USD Sale Jul-12 VMware 1260 Network US Merchant Trade Business e-Solutions, Inc. Mar-00 3i, Trident Capital 7 USD Sale Jul-12 Cielo S.A. 670 Services US Elevation Canaan Partners, Care Capital, Mesa Sunovion Pharmaceuticals, Jan-10 Verde Venture Partners, Novo Ventures, 77 USD Trade Aug-12 Pharmaceuticals 430 Pharmaceuticals US Inc. TPG Biotech Sale Inc. Generation Investment Management, AgraQuest, Inc. Dec-07 Loudwater Investment Partners, Otter 38 USD Trade Jul-12 Bayer 425 Chemicals US Capital Sale CropScience AG , , Accel Partners, DST Global, Elevation Partners, Firsthand Technology Value Fund, General Atlantic, , * Sep-04 , GSV Capital, Hercules 2,617 USD Stock Aug-12 - 395.8 Internet US Technology Growth Capital, Meritech Sale Capital Partners, , T Rowe Price, The Founders Fund Management, TriplePoint Capital *Denotes a partial exit. Source: Preqin Venture Deals Analyst

21 © 2012 Preqin Ltd. / www.preqin.com